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Summary The DNA damage and the sequence specificity of guanine-N7 alkylation produced by the novel,
positively charged, antineoplastic agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Da-
bis maleate) and its uncharged tertiary amine analogue 1,4-bis(2'-chloroethyl)-1,4-diazacyclohexane (Dabis
analogue) were investigated in L1210 cells and isolated DNA. Both compounds are cytotoxic in vitro causing
an arrest of L1210 cells in G2/M phase of the cell cycle. In isolated DNA, Dabis maleate alkylates guanine at
the N7-position with some differences in specificity compared to other alkylating agents (e.g. nitrogen
mustard). Significant differences are also evident between Dabis maleate and Dabis analogue, suggesting that
Dabis analogue is not the sole alkylating species of Dabis maleate. Using the alkaline elution technique a
moderate number of DNA interstrand cross-links were detected in L1210 cells treated with both compounds,
which were completely repaired within 24 h. Dabis maleate and Dabis analogue do not cause DNA single
strand breaks or DNA protein cross-links at the doses at which DNA interstrand cross-links were detected.
1,4-bis(2'-chloroethyl)- 1,4-diazabicyclo-[2.2.1] heptane dima-
leate (Dabis maleate, NSC 262666, see structure in Figure 7a)
is one of a series of quaternary ammonium salts which has
been synthesised (Fessler et al., 1969) and tested for anti-
tumour activity. Dabis maleate and Dabis perchlorate were
found to be active in several tumour systems of mice and
rats, including L1210 leukaemia, colon 26, Lewis lung car-
cinoma and Walker 256 carcinosarcoma (Pettit et al., 1979).
The activity of the two drugs was similar, but since Dabis
perchlorate is potentially explosive, further studies were con-
ducted with Dabis maleate.
In order to elucidate the mode of action of this drug,
which is undergoing phase I clinical trials, we undertook this
study in which we characterised the DNA damage in intact
cells and the sequence specificity of guanine-N7 alkylation in
isolated DNA.
These studies were conducted in parallel with the un-
charged tertiary amine 1,4-bis(2'-chloroethyl)-1,4-diazacyclo-
hexane (Dabis analogue, see structure in Figure 7c) lacking
the bridge between the two nitrogen atoms to determine to
what extent the positive charges present in the Dabis maleate
molecule could play a role in the mechanism of action of this
drug. A comparison of the pattern of N7-guanine alkylation
of Dabis maleate and Dabis analogue could give an indica-
tion of the mechanism of alkylation of this novel anti-cancer
agent.
Materials and methods
Drugs
Dabis maleate and Dabis analogue were obtained from Dr
Winograd of the New Drug Developmental Office (Amster-
dam) and from the Drug Developmental Program, Division
of Cancer Treatment (NCI, Bethesda, Maryland).
Plasmid DNAs and restriction endonucleases were pur-
chased from Bethesda Research Laboratories; T32P-ATP (spe-
cific activity 5,000 Ci mmol-') was obtained from Amersham.
All the other reagents were of the greatest available purity.
*Present address: Department of Oncology, University College and
Middlesex School of Medicine, London, UK.
'Present address: ICI Amencas Inc., Agricultural Products Environ-
mental Health Center, Farmington, CT, USA.
Correspondence: M. Broggini.
Received 24 April 1989; and in revised form 4 October 1989.
Cell cytotoxicity
Exponentially growing L1210 cells were treated with different
concentrations of Dabis maleate and Dabis analogue for 1 h
at 37°C. At the end of treatment cells were washed with
phosphate-buffered saline (PBS) and resuspended in drug-free
medium. After 48 h cells were diluted with fresh medium to
maintain the concentration between 0.3 and 1.5 x 106
cells ml-'. In this range the growth of control cells is log-
arithmic. The effect of drugs on cell growth was evaluated
after recovery times of 24, 48 and 72 h using a Coulter
Counter model ZB (Kontron).
The effects of drug treatment on cell cycle phase distri-
bution were evaluated after a recovery time of 24, 48 and
72 h using a 30-L cytofluorograph (Ortho Diagnostic System,
USA). One ml of L1210 cells was centrifuged for 10 min at
1,200 r.p.m. and directly stained with 1 ml of propidium
iodide (PI) solution (Calbiochem Behring, USA) containing
50pg ml-' of PI in 0.1% sodium citrate and 7.5gg of RNase
(Calbiochem Behring, USA) in water at room temperature
for 15min (Erba et al., 1986).
The fluorescence pulse was detected in a spectral range
between 580 and 750 nm; the coefficient of variation of the
GI peak of the L1210 cells was about 4-5%. Each
cytofluorimetric assay was performed with 1-2 x 104 cells.
Sequence specificity ofguanine-N7 alkylation
The method has been previously described in detail (Mattes
et al., 1986). Briefly, Bam HI digested pBR322 DNA was
32P-labelled at its 5' ends with T4 polynucleotide kinase and
732P-ATP (Maxam & Gilbert, 1980). A second cut with Sal I
was performed to produce a 276 bp fragment labelled at only
one end which was isolated from agarose gels. Alkylation
was performed in 25 mM triethanolamine, 1 mM EDTA,
pH 7.2, at 37°C or room temperature for different times at
doses selected to give approximately one alkylation per DNA
molecule. After precipitation and washing the DNA was
treated for 15 min at 90°C with 1 M piperidine to produce
breaks specifically at sites of guanine-N7 alkylation.
DNA fragments were separated on 0.4 mm, 6% polyacryl-
amide gels containing 7 M urea and a Tris-boric
acid-EDTA buffer system. Gels were run at 85 W (approx-
imately 3,500 V) for 3 h. Following autoradiography of the
gel, relative band intensities were determined by microden-
sitometry using a Beckman DU-8 scanning spect-
rophotometer with gel scanning accessory.
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DNA damage in intact cells
L1210 cells growing in RPMI 1640 were labelled with 3H-
thymidine (specific activity 20 Ci mmol '; NEN) for 24 h at a
concentration of 0.1 tCi ml-' in medium containing 10-6 M
unlabelled thymidine. After 16-24 h chasing in medium with-
out 3H-thymidine, cells were treated for I h with 400 tLM
Dabis maleate or 4gAM Dabis analogue. At the end of treat-
ment or after 6 and 24 h of post incubation in drug-free
medium, DNA single strand breaks (DNA-SSB), DNA
interstrand cross-links (DNA-ISC) and DNA-protein cross-
links were determined by the alkaline elution technique
(Kohn et al., 1981).
For the DNA-SSB, cells were washed in ice cold PBS and
layered on polycarbonate filters, 0.8jtm pore size and 25 mm
diameter. Cells were then lysed with a solution containing
2% sodium dodecyl sulphate, 0.02M EDTA, 0.1M glycine,
pH 10.0 (lysis solution), which was allowed to flow through
the filter by gravity. After connection of the outlet of the
filter holders to the pumping system, 2 ml of proteinase K
(0.5 mg ml-' dissolved in lysis solution) were added to a
reservoir over the polycarbonate filters and pumped for ap-
proximately 1 h at a rate of 0.35 ml min'l. DNA was eluted
from the filters by pumping 0.02 M EDTA solution adjusted
to pH 12.1 with tetrapropylammonium hydroxide containing
0.1% sodium dodecyl sulphate through the filters at approx-
imately 2 ml h-'. Fractions were collected 3-hourly, with
fractions and filters processed as described (Kohn et al.,
1981).
For the DNA-protein cross-links, cells were layered on
DM 800 Metricel filters, 2pm pore size and 25 mm diameter
and then lysed with 5 ml of 2 M NaCl, 0.04 M EDTA, 0.2%
N-laurylsarcolisine, pH 10.0. The detergent was then washed
away with 5 ml of 0.02 M EDTA solution. The elution buffer
was the same as that used for DNA single-strand breaks,
pH 12.1, except that no sodium dodecyl sulphate was added.
For the DNA-ISC, cells were irradiated with 450 rad at
0°C and then layered on filters and processed as described for
the DNA-SSB.
Results
Figure I shows the cell growth inhibition effect on L1210
cells exposed in vitro for 1 h at different concentrations of
Dabis maleate and Dabis analogue and evaluated after re-
covery times of 24, 48 and 72 h. Both drugs cause an inhib-
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Figure 1 Cell growth inhibition of different doses of Dabis
maleate and Dabis analogue at the concentrations indicated in
the figure after I h treatment of L1210 cells. -*- Control; -0-
Dabis maleate 200tLM; - - Dabis maleate 400AM; -0 - Dabis
maleate 800ftM; -A - Dabis analogue I gM; -A - Dabis
analogue 2tiM; -0- Dabis analogue 4l4M.
ition of cell growth in a dose-dependent manner with Dabis
analogue showing the same effects as Dabis maleate but at
200-fold lower concentrations.
The effects of Dabis maleate and Dabis analogue on cell
cycle phase distribution are shown in Figure 2. One hour
treatment with both compounds induces an accumulation of
cells in late S-G2M phases (SL-G2M) that, for the highest
dose (Dabis maleate 8001LM and Dabis analogue 41M), is
still evident after 48 h recovery time, but reverting to normal
after 72 h. Again, Dabis analogue shows the same pattern of
cell cycle arrest at concentrations that are 200 times lower
than those required for Dabis maleate.
In order to determine whether or not the alkylation reac-
tions of Dabis maleate and of Dabis analogue are due to the
same reactive species, the intensity patterns for reactions with
guanines in a defined DNA segment were compared. If the
proximal reactive species are the same, then the reaction
intensity patterns should be identical. Figure 3a and c shows
that there are significant differences between the two com-
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Figure 2 Cell-cycle phase distribution of L1210 cells in vitro exposed for I h at 37'C, at the concentrations indicated, to Dabis
maleate and Dabis analogue and evaluated after 24, 48 and 72 h recovery.SEQUENCE SPECIFIC DNA BINDING OF DABIS MALEATE 287
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Figure 3 Densitometric scans of guanine-N7 alkylation pro-
duced in the 276 bp Bam HI-Sal I fragment of pBR322 5' end
labelled at Bam HI site. Panel a, 1 mM Dabis maleate for I h at
room temperature. b, 1001JM Dabis maleate for I h at 37°C. c,
I ILM Dabis analogue for I h at room temperature. The corres-
pondence between nucleotide positions 458 and 549 is shown
along the abscissa. Arrows point to some major differences
between the patterns.
pounds at certain sites. The most notable difference is at
guanine 524 (for sequence see Figure 4), which, relative to
other guanines, reacts much more intensely with Dabis ana-
logue than with Dabis maleate (arrow in Figure 3c). Gua-
nines 536, 537 and 538 react more weakly with Dabis
analogue than with Dabis maleate (arrows in Figure 3a). In
addition, the major peaks located at the central G at position
472 and at position 486 are relatively weaker for Dabis
maleate than for Dabis analogue; in both cases the sequente
about the central G is 5'-CGGGC-3'.
The above reactions were carried out at room temperature
at doses which gave comparable levels of alkylation. When
Dabis maleate was reacted at 37°C, the intensity pattern was
shifted part of the way toward that seen with Dabis analogue
(Figure 3b). The reason for this will be considered in the
Discussion. By contrast the reaction pattern produced by
Dabis analogue was essentially identical at room temperature
5'-GGCAGGCCCCGTGGCCGGGGGACTG-3'
Figure 4 DNA sequence showing the locations of major
differences between Dabis maleate and Dabis analogue. The up
arrow indicates higher reaction intensity in Dabis analogue than
in Dabis maleate; down arrows indicate the reverse.
and at 37°C (data not shown). For the purpose oforientation
relative to a standard nitrogen hnustard, the intensity pattern
for reaction with N,N-bis(2-chloroethyl)-N-methylamine
(HN2) in the same DNA region is shown in Figure 5. The
pattern is similar (although not identical) to that obtained for
Dabis maleate at room temperature (Figure 3a).
Figure 6 shows the formation of DNA-ISC in L1210 cells
treated for I h with 400)M Dabis maleate and 4pM Dabis
analogue. Both compounds produced slight, but significant,
DNA-ISC at the end of treatment which were still present
after 6 h of post incubation in drug-free medium (approx-
imately 30-50 rad equivalents). By 24 h no DNA-ISC were
evident, suggesting that the few DNA-ISC formed were
already repaired.
Neither compound produced any detectable DNA-SSB or
DNA-protein cross-links (data not shown) as assessed by
alkaline elution at the doses at which DNA-ISC were de-
tected and at which significant growth inhibition was ob-
served.
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Figure 5 Densitometric scan of guanine-N7 alkylation produced
by 20 tLM HN2 for I h at room temperature. DNA fragment-
analysed is the same as in Figure 3 but is from a separate gel.
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Figure 6 Formation of DNA-ISC in 1210 cells treated with
Dabis maleate (400 iM) or Dabis analogue (4wM) for I h and
evaluated at different recovery times as indicated. All the samples
were irradiated with 450 rad before alkaline elution. Controls are
not irradiated cells. For details see Materials and methods. - O -
Control; -0- 450 rad; -0- Dabis maleate Oh; -O- Dabis
maleate 6 h; - * - Dabis maleate 24 h; -*- Dabis analogue Oh;
-A- Dabis analogue 6h; -A- Dabis analogue 24h.
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Discussion
We confirm that Dabis maleate is cytotoxic against L1210
leukaemia cells, causing an arrest in late S or G2 phase ofthe
cell cycle (Traganos et al., 1984). The induction of a block in
late S or G2 is a common feature of many DNA damaging
antineoplastic drugs and would suggest that Dabis maleate
and the more toxic Dabis analogue interact with DNA.
Although direct alkylation by Dabis maleate is unexpected,
since chemical mechanisms would not predict alkylating
reactivity of the quaternary amino groups, we found that
Dabis maleate did lead to alkylation of guanine-N7 positions
in isolated DNA. The low potency of Dabis maleate com-
pared to other alkylating agents such as nitrogen mustard
suggested the possibility that the compound may convert
chemically to a tertiary amine form with alkylating activity.
A chemically plausible mechanism (Pettit et al., 1979) would
be the loss of the bridging CH2 as formaldehyde to yield the
tertiary amine Dabis analogue (Figure 7c). If this were the
sole alkylating species generated, then the reactivity pattern
for Dabis maleate should be identical to that of Dabis
analogue. We found, however, that the two compounds
exhibit clear differences in the pattern of guanine-N7 alkyla-
tion intensities in a DNA sequence. This excludes the pos-
sibility that the proximal reactive species produced by Dabis
maleate and Dabis analogue are identical.
A simple hypothesis proposed here is that the loss of the
bridging CH2 from Dabis maleate occurs in two steps and
that an intermediate, possibly an aldehyde, as indicated in
Figure 7b, or a hydroxymethyl derivative, persists long
enough to contribute significantly to the alkylation reactions.
The hypothesised intermediate has both a tertiary and a
quaternary 2-chloroethylamino group, and the tertiary group
should be able to initiate alkylation reactions.
The aldehyde (or hydroxymethyl) group in Figure 7b
would be present in the transition state of the alkylation
reaction and therefore could affect the relative reaction rates
at different guanines, depending upon the DNA sequence
environment. This mechanism provides an explanation for
the temperature dependence of the sequence selectivity of
Dabis maleate seen in Figure 3. At the higher temperature
(37°C), the intermediate species would decompose faster to
Dabis analogue (Figure 7c) and therefore would contribute
less to the overall reaction. This would be in accord with the
finding that, at the higher temperature, there is less difference
between the reaction patterns of Dabis maleate and Dabis
analogue. The pattern of guanine-N7 alkylation of Dabis
maleate is similar to, but not the same as, that of nitrogen
mustard. For example, alkylation of three adjacent guanines
in a run of five guanines is much greater than for the
nitrogen mustard, which produces intense alkylation in only
one of the five guanines.
As previously observed for nitrogen mustards (Ewig &
Kohn, 1977; Ross et al., 1978) no DNA-SSB were detected in
L1210 cells treated with Dabis maleate or Dabis analogue. In
contrast to nitrogen mustard, however, no DNA-protein
cross-links were detected at doses at which DNA-ISCs were
produced. The only lesions detected at doses which produced
an inhibition of cell growth were DNA-ISCs suggesting that
they were cytotoxic to the cells. The nature of the low level
of DNA-ISCs produced remains to be determined, and may
differ from that of those produced by other alkylating agents,
such as nitrogen mustards, because of the differing distance
between the two alkylating moieties within the drug mole-
cules.
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Figure 7 Chemical structure of Dabis maleate (a) and Dabis
analogue (c). Compound (b) is the possible reactive species of
Dabis maleate.
In conclusion, the novel agent Dabis maleate appears to be
similar to conventional bifunctional alkylating agents such as
nitrogen mustards in that it produces DNA-ISC and a cell
cycle arrest in G2M at pharmacologically relevant doses, but
differs in that it produces a different pattern of guanine-N7
alkylation in purified DNA and no evidence of DNA-
protein cross-links in cells. The tertiary amine Dabis ana-
logue, which was found to be very toxic in vivo (Pettit et al.,
1979), was active in vitro at 200-fold lower concentrations,
but the different patterns of alkylation produced by this
compound suggest that this is not the sole alkylating species
of Dabis maleate.
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